SCHEMBL8690259

SCHEMBL8690259

COc1ccc2cc(C(C)C(=O)N(C)CC(O)c3ccc(O)c(O)c3)ccc2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 6/20 0.51
AKR1C2 P52895 6/20 0.51
PTGS2 P35354 4/20 0.51
PTGS1 P23219 3/20 0.51
TSHR P16473 2/20 0.51
CDC42 P60953 1/20 0.51
RAC1 P63000 1/20 0.51
CYP1A2 P05177 1/20 0.51
SLC22A6 Q4U2R8 1/20 0.51
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
LMNA P02545 1/20 0.49
MAPT P10636 1/20 0.49
CYP2C9 P11712 1/20 0.49
TDP1 Q9NUW8 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
OPRM1 P35372 1/20 0.47
OPRD1 P41143 1/20 0.47
ALOX5 P09917 1/20 0.44
ABCB11 O95342 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL328574 0.73 TDP1 (0.51) PTGS2TSHRCYP1A2MEN1KMT2A
SCHEMBL9288960 0.73 PTGS2 (0.68) AKR1C3AKR1C2PTGS2PTGS1TSHR
SCHEMBL23040664 0.72 KDM4E (0.53) PTGS2TSHRCYP1A2MEN1KMT2A
SCHEMBL23040663 0.72 KDM4E (0.53) PTGS2TSHRCYP1A2MEN1KMT2A
SCHEMBL23318970 0.72 MAPT (0.46) PTGS2TSHRCYP1A2MEN1KMT2A
Naproxen SCHEMBL11721059 0.71 AKR1C3 (0.91) AKR1C3AKR1C2PTGS2PTGS1TSHR
SCHEMBL5828705 0.70 AOC3 (0.50) PTGS2TSHRCYP1A2MEN1KMT2A
SCHEMBL38651836 0.70 AKR1C3 (0.58) AKR1C3AKR1C2PTGS2PTGS1TSHR
SCHEMBL60543 0.70 AKR1C3 (0.58) AKR1C3AKR1C2PTGS2PTGS1TSHR
SCHEMBL15116646 0.69 PTGS2 (0.81) AKR1C3AKR1C2PTGS2PTGS1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811438-A USEFUL FOR PREVENTING OR ALLEVIATING TISSUE EDEMA, CONJUNCTIVA SWELLING AND CONGESTION OR CORNEAL HAZE ALCON LABORATORIES, INC. (US) 1998-09-22 US disclosed
EP-0799219-A2 ESTERS AND AMIDES OF NON-STEROIDAL ANTI-INFLAMMATORY CARBOXYLIC ACIDS WHICH MAY BE USED AS ANTI-OXIDANTS, 5-LIPOXYGENASE INHIBITORS AND NON-STEROIDAL ANTI-INFLAMMATORY PRODUCTS ALCON LABORATORIES, INC. (US) 1997-10-08 EP disclosed
US-5643943-A NONSTEROIDAL ANTIINFLAMMATORY AGENTS FOR VASCULAR INFLAMMATION ALCON LABORATORIES, INC. (US) 1997-07-01 US disclosed
US-5607966-A BENZOFURAN OR BENZOPYRAN DERIVATIVES ALCON LABORATORIES, INC. (US) 1997-03-04 US disclosed
WO-1996020187-A2 ESTERS AND AMIDES OF NON-STEROIDAL ANTI-INFLAMMATORY CARBOXYLIC ACIDS WHICH MAY BE USED AS ANTI-OXIDANTS, 5-LIPOXYGENASE INHIBITORS AND NON-STEROIDAL ANTI-INFLAMMATORY PRODUCTS ALCON LABORATORIES, INC. (US) 1996-07-04 WO disclosed